Aurora Spine Corporation (TSXV: ASG) has announced an amendment to an existing loan from a company insider, increasing the available principal by US$200,000 to bring the total outstanding to US$2.4 million. The Carlsbad, California-based spinal implant manufacturer says proceeds will be directed toward general corporate purposes. The transaction is classified as a related party transaction under applicable Canadian securities regulations, though it qualifies for exemptions from formal valuation and minority approval requirements. Investors may be watching how this additional financing supports the company's near-term operational needs.

Key Points

  • Aurora Spine Corporation (TSXV: ASG) announced an amendment to an existing insider loan arrangement
  • An insider agreed to increase the loan's principal by US$200,000, bringing the total principal to US$2.4 million
  • The promissory note bears interest at 4.5% per annum, with the full amount due on July 11, 2029
  • Investors should monitor whether all necessary approvals are received to finalise the amended loan

Insider Increases Loan Principal to US$2.4 Million for Aurora Spine

An insider of Aurora Spine Corporation has agreed to increase the principal amount available under an existing promissory note by US$200,000, according to the company's announcement dated September 29, 2026. This brings the total principal amount owed by the company to that insider to US$2.4 million. Aurora Spine states it intends to use the proceeds for general corporate purposes. The loan remains subject to certain conditions, including receipt of all necessary regulatory approvals, and the company noted it was not in a position to file a material change report more than twenty-one days in advance of the loan's completion.

Promissory Note Terms: Interest Rate, Maturity, and Prepayment Flexibility

The amended loan is evidenced by a promissory note bearing interest at 4.5% per annum. Both the principal amount and accrued interest are due on July 11, 2029. Aurora Spine retains the right to prepay the principal and interest, in whole or in part, at any time without penalty, which provides the company with repayment flexibility. Notably, if a Change of Control event occurs, the maturity date will be accelerated and the full balance becomes due and payable upon written request from the holder. Aurora Spine's wholly owned subsidiary, Aurora Spine, Inc., continues to provide a guarantee and security for the obligations under the note.

Related Party Transaction Exemptions Under MI 61-101

Aurora Spine disclosed that the amended loan constitutes a related party transaction within the meaning of Multilateral Instrument 61-101 — Protection of Minority Security Holders in Special Transactions, as well as TSX Venture Exchange policies. The company states the transaction is otherwise exempt from the formal valuation and minority shareholder approval requirements of MI 61-101. The TSX Venture Exchange and its Regulation Services Provider have not accepted responsibility for the adequacy or accuracy of the release, as is standard for TSXV-listed issuers. The immediate share price impact was not clear from available public information.